To exclude nonspecific cell toxicity of GDC-0623, we tested CAMA-1 breast cancer cells, which we found consistent with published reports15 to be insensitive to MEK inhibition (Fig. 2c). The gene discussed is MAP2K7; the disease is breast cancer.